Revatis

TLDR

Revatis develops patented technology to obtain multipotent adult mesenchymal stem cells from minimally invasive muscle micro-biopsies for regenerative medicine and cell therapy.

Overview

Revatis S.A. is a spin-off from the University of Liège dedicated to regenerative medicine and cell therapy. The company has developed patented technology for obtaining multipotent stem cells from muscle micro-biopsies, with applications in veterinary clinical medicine and human medical research.